LLY•benzinga•
Cantor Fitzgerald Initiates Coverage On Eli Lilly with Overweight Rating, Announces Price Target of $975
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on April 22, 2025 by benzinga